Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online July 17, 2008
Stem Cells Vol. 26 No. 9 September 2008, pp. 2444 -2454
doi:10.1634/stemcells.2008-0116; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2008-0116v1
26/9/2444    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johansson, S.
Right arrow Articles by Modo, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johansson, S.
Right arrow Articles by Modo, M.

TISSUE-SPECIFIC STEM CELLS

Effect of Inflammatory Cytokines on Major Histocompatibility Complex Expression and Differentiation of Human Neural Stem/Progenitor Cells

Saga Johansson, Jack Price, Michel Modo

Centre for Cellular Basis of Behaviour, King's College London, Institute of Psychiatry, London, United Kingdom

Key Words. Neural stem cell • Major histocompatibility complex • Cytokines • Cell differentiation • Graft rejection

Correspondence: Correspondence: Dr. Mike Modo, Ph.D., Centre for the Cellular Basis of Behavior, The James Black Centre, Institute of Psychiatry, King's College London, 125 Coldharbour Lane, London SE5 9NU, United Kingdom. Telephone: +44-[0]2078485315; Fax: +44-[0]2078485308; e-mail: mike.modo{at}iop.kcl.ac.uk CCBB Web site: http://www.ccbb.iop.kcl.ac.uk

Received on February 6, 2008; accepted for publication on July 1, 2008.

First published online in STEM CELLS EXPRESS  July 17, 2008.


To develop transplantation of neural stem/progenitor cells (NSPCs) as a successful treatment of neurodegenerative disorders, the possible induction of an inflammatory response following implantation needs to be taken into consideration. Inflammatory cytokines can upregulate major histocompatibility complex (MHC) expression on transplanted cells, thereby rendering them more susceptible to graft rejection. Furthermore, cytokines also have a profound effect on cell differentiation, migration, and proliferation, which can greatly affect the outcome of transplantation. Here we studied the effect of three inflammatory cytokines, interferon-{gamma} (IFN-{gamma}), tumor necrosis factor-{alpha} (TNF-{alpha}), and interleukin-6 (IL-6), from three different species (human, monkey, rat) on expression of MHC molecules and differentiation of two human NSPC lines derived from striatum and hippocampus. Human and monkey IFN-{gamma} strongly upregulate MHC expression in both NSPC lines in a dose-dependent manner, whereas rat IFN-{gamma} has an effect on MHC expression only in hippocampal cells. Furthermore, TNF-{alpha}, but not IL-6, upregulates MHC expression in both NSPC lines. Differentiation of NSPCs in the presence of cytokines showed that IFN-{gamma} increased the neuronal yield threefold in striatal NSPC cultures and increased the number of oligodendrocytes twofold in hippocampal NSPC cultures. Addition of TNF-{alpha} enhanced gliogenesis in both cell lines, whereas IL-6 stimulated neurogenesis. Human NSPC lines' response to cytokines is therefore species specific and also dependent on the NSPCs' region of origin. The successful translation of different cell lines from animal models to clinical trials could be substantially influenced by the species-specific regulation of MHC and differentiation as reported here.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
DMMHome page
P. A. Walker, S. K. Shah, M. T. Harting, and C. S. Cox Jr
Progenitor cell therapies for traumatic brain injury: barriers and opportunities in translation
Dis. Model. Mech., January 1, 2009; 2(1-2): 23 - 38.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.